Research progress of the mechanism on intraocular neovascularization

International Journal of Ophthalmology

Volumn 8, Issue 12, 2008, Pages 2496-2498

  Xu, Jian Hua ^a   Li, Ruo Xi ^a   Zhang, Wei ^a   Qi, Fei ^a  

^a Shenyang Institute of Eye Diseases   (China)

Author keywords

Angiogenesis; Diabetic retinopathy; Neovascularization; Retinopathy of prematurity

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ARTICLE; CHOROID; DIABETIC RETINOPATHY; EYE DISEASE; HUMAN; MEDICAL RESEARCH; NEOVASCULARIZATION (PATHOLOGY); OCULAR BLOOD VESSEL; RETINA BLOOD FLOW; RETINA MACULA AGE RELATED DEGENERATION; RETROLENTAL FIBROPLASIA;

EID: 58249144478     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Yan Y, Wang L. Recent advance of the study on pathogenesis of age-related macular degeneration. Int J Ophthalmol (Guoji Yanke Zazhi) 2008;8(9):1888-1890
2. Frank RN, Amin RH, Eliott D, et al. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 1996; 122 (3):393-403
3. Lopez PF, Sippy BD, Lambert HM, et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996; 37(5):855-868
4. Shen WY, Yu MJ, Barry CJ, et al. Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. Br J Ophthalmol 1998;82(9):1063-1071
5. Honda M, Sakamoto T, Ishibashi T, et al. Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/ flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration. Gene Ther 2000;7(11):978-985
6. Krzystolik MG, Afshari MA, Adamis AP, et al. Prevention of experimental choroidal neovasculanzation with intiravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002;120(3): 338-346
7. Schwesinger C, Yee C, Rohan RM, et al. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol 2001;158(3):1161-1172
8. Ogata N, Matsushima M, Takada Y, et al. Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization. Curr Eye Res 1996;15(10):1008-1018
9. Tobe T, Ortega S, Luna JD, et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 1998;153(5):1641-1646
10. Yamada H, Yamada E, Kwak N, et al. Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina. J Cell Physiol 2000;185(1):135-142
11. Takahashi T, Nakamura T, Hayashi A, et al. Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells. Am J Ophthalmol 2000;130(6):774-781
12. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285 (5425): 245-248
13. Gao G, Li Y, Zhang D, et al. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization, FEBS Lett 2001; 489(2-3):270-276
14. Holekamp NM, Bouck N, Volpert O. Pigment epitheliumderived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol 2002;134(2): 220-227
15. Green WR, Enger C. Age-related macular degeneration histopathologic studies. Ophthalmology 1993;100(10):1519-1535
16. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987;31(5):291-306
17. Del Priore LV, Hornbeck R, Kaplan HJ,et al. Debridement of the pig retinal pigment epithelium in vivo. Arch Ophthalmol 1995;113(7): 939-944
18. Blaauwgeers HG, Holtkamp GM, Rutten H, et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 1999;155(2):421-428
19. Chow J, Ogunshola O, Fan SY, et al. Astrocyte-derived VEGF mediates survival and tube stabilization of hypoxic brain microvascular endothelial cells in vitro. Brain Res Dev Brain Res 2001;130(1):123-132
20. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994;35(1):101-111
21. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995;7;92(23):10457-10461
22. Chan-Ling T, Gock B, Stone J. Supplemental oxygen therapy. Basis for noninvasive treatement of retinopathy of prematurity. Invest Opthalmol Vis Sci 1995;36(7):1215-1230
23. Shima DT, Gougos A, Miller JW, et al. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fasicularis. Invest Ophthalmol Vis Sci 1996;37(7):1334-1340
24. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of VEGF prevents ocular neovascularization in a primate.Arch Ophthalmol 1996;114(1): 66-71
25. Malecaze F, Clamens S, Simorre-Pinatel V,et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factorlike activity in proliferative diabetic retinopathy. Lab Sci 1994;112(11):1476-1482